Clinically Applicable Diagnostics Assay Development for Lung Cancer Biomarker, SAA

Volume: 7, Issue: 10, Pages: 1 - 7
Published: Sep 8, 2014
Abstract
Background: Serum Amyloid A (SAA) is an acute phase protein and has been reported as a lung cancer biomarker. Many cancer protein biomarkers have been reported but few are currently in clinical application. This is due to the obstacles in the process from biomarker discovery to biomarker application: validation in large scale clinical samples and paired antibody production for the development of immunoassay-based diagnostics. Methods: To...
Paper Details
Title
Clinically Applicable Diagnostics Assay Development for Lung Cancer Biomarker, SAA
Published Date
Sep 8, 2014
Volume
7
Issue
10
Pages
1 - 7
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.